Some outcomes were microbiome-linked: • AG ↓ ghrelin, linked to shifts in microbial CAZyme genes targeting AG’s specific glycan structures. • ML models predicted BP improvements with AG and CRP reductions with RS4 from microbial pathways and faecal bile acids.